Clinical Trial Update: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma [NA]

View source ↗

Summary

This clinical trial update describes evaluating 18F-FDG PET/CT with liver SUVmax-based criteria to prognosticate outcomes in patients with extranodal natural ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lymphoma, Extranodal NK-T-Cell | NA | Status: UNKNOWN